Martinsried

DGAP-News: 4SC AG provides results for financial year 2019 and outlook

Wednesday, March 25, 2020 - 7:00am

Planegg-Martinsried, Germany, 25 March 2020 - 4SC AG (4SC, FSE Prime Standard: VSC) today published the financial results for the financial year ended 31 December 2019, presenting all material reporting period developments and provides an outlook for 2020.

Key Points: 
  • Planegg-Martinsried, Germany, 25 March 2020 - 4SC AG (4SC, FSE Prime Standard: VSC) today published the financial results for the financial year ended 31 December 2019, presenting all material reporting period developments and provides an outlook for 2020.
  • As of 31 December 2019, 4SC holds cash balance/funds of 45,765 thousand (31 December 2018: 25,036 thousand).
  • For 2020, 4SC is expecting an average monthly use of cash from operations of between 2,200 thousand and 2,600 thousand.
  • 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs.